First-line FOLFOXIRI In Combination With Bevacizumab For Metastatic Colorectal Cancer (FOIB)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Gruppo Oncologico del Nord-Ovest
ClinicalTrials.gov Identifier:
NCT01163396
First received: July 9, 2010
Last updated: March 10, 2015
Last verified: March 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2010
  Primary Completion Date: April 2009 (Final data collection date for primary outcome measure)